Qisda Corporation completed the acquisition of additional 5% stake in Norbel Baby Co., Ltd.
May 14, 2023
Share
Qisda Corporation (TWSE:2352) made a bid to acquire additional 5% stake in Norbel Baby Co., Ltd (TPEX:6844) for approximately TWD 370 million on April 21, 2023. As of April 26, 2023, the deal value per share is TND 210, and accumulated tendered shares have reached 1.754 million, exceeding the planned minimum amount of 1.753 million. The transaction is funded through Qisda Corporation's own funds. The tender offer by the Company to acquire NORBEL's common shares will continue until on May 15, 2023. All the conditions of this tender offer have been satisfied. Lai Ming-Yang of WeTec International CPAs acted as accountant to Qisda Corporation.
Qisda Corporation (TWSE:2352) completed the acquisition of additional 5% stake in Norbel Baby Co., Ltd (TPEX:6844) on May 15, 2023.
Norbel Baby Co Ltd is a Taiwan-based company mainly engaged in the pharmacy chain and pharmacy channel business. The Company is engaged in the sale of professional pharmaceuticals, medical care, health care, women's and children's products, medical beauty products and related consulting services. The Company is engaged in the provision of sales and services for women's and children's products, pharmaceuticals, and health care products. The Company's products include baby milk powder, diapers, maternity and baby products and other women's and infant products; health care drugs such as health food and drugs for children, adults and silver hair; health care products such as adult milk powder and diapers, medical equipment, and home living products. The company sells its products mainly in China.